Table 3.
The frequency of MTRR c.66A>G polymorphism in breast cancer patients compared to control group
MTRR
c.66A>G |
Patients n= 99 n (%) |
Controls n=141 n (%) |
χ2, P |
---|---|---|---|
Genotype | |||
AA | 18 (18.2) | 15 (10.6) | - |
AG | 65 (65.7) | 107 (75.9) | 2.88, 0.09 |
GG | 16 (16.1) | 19 (13.5) | 0.36, 0.54 |
Allele | |||
A | 101 (51) | 137 (48.6) | 0.19, 0.65 |
G | 97 (49) | 145 (51.4) |
Overall χ2= 3.28, P-value=0.19